12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
Clinical trial NCT02363738 · COMPLETED
Trial details
- NCT number
- NCT02363738
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.